Delivery Order SPE2DR25D3109-SPE2DR26FT2HH
- Not listed
- The Defense Logistics Agency (DLA) awarded a $12,636.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on August 29, 2025, with a completion date of September 2, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $12,946.33 on November 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pens. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by November 13, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains significant pharmaceutical distribution and healthcare supply operations...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $17,749.40 for Zepbound 2.5 mg/0.5 ml pens with a completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The product will be performed at the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and...
- The Defense Logistics Agency awarded a $2,287.74 delivery order to AmerisourceBergen Drug Corp on February 11, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. The contract is classified as firm fixed price with no set-aside designation, indicating it was awarded through open competition. Performance will be completed by February 12, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $39,945.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injections on December 11, 2025, with completion scheduled for December 12, 2025. This non-competitive, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,571.34 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on December 2, 2025. This competitive delivery order, utilizing firm fixed pricing with no set-aside designation, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens valued at $9,721.62. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a $36,746.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $1,845.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL), with an ultimate completion date of November 5, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,262.98 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on November 18, 2025, with a completion date of November 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single-use transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's headquarters location in...
- SPE2DR25D3109Indefinite Delivery Contract
- SPE2DR25D3109-SPE2DR26FT2HHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,388.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, serves as a prime vendor for the DLA Medical Supply Chain. The company supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and other critical medical commodities. This Zepbound delivery order falls within AmerisourceBergen's extensive pharmaceutical procurement activities with the DLA, which consistently leverage firm fixed-price delivery orders to fulfill federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/4/25 |